The genetic epidemiology of breast cancer genes

scientific article

The genetic epidemiology of breast cancer genes is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1035427468
P356DOI10.1023/B:JOMG.0000048770.90334.3B
P698PubMed publication ID15557796

P50authorDeborah ThompsonQ73218846
Douglas F. EastonQ59812154
P2860cites workHeterozygous germ line hCHK2 mutations in Li-Fraumeni syndromeQ22011001
Dominant Negative ATM Mutations in Breast Cancer FamiliesQ22066027
Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patientsQ24170410
Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1Q24321914
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesQ24531993
Study of a single BRCA2 mutation with high carrier frequency in a small populationQ24680535
How many more breast cancer predisposition genes are there?Q24800566
BRCA2 mutation carriers, reproductive factors and breast cancer riskQ24803237
Molecular portraits of human breast tumoursQ28032461
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and FinlandQ28140600
BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the diseaseQ64050126
Segregation and linkage analysis of nine Utah breast cancer pedigreesQ67929669
Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer GroupQ67979093
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancerQ70812480
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkageQ71046679
Germline BRCA1 185delAG mutations in Jewish women with breast cancerQ71107825
BRCA2 germline mutations in male breast cancer cases and breast cancer familiesQ71167609
A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individualsQ71400891
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 geneQ71955901
Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family StudyQ73022855
Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer familiesQ73085107
Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study GroupQ73108544
BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancerQ73109324
Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general populationQ73139263
Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer familiesQ73259292
Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer familiesQ73282154
Familial invasive breast cancers: worse outcome related to BRCA1 mutationsQ73300388
Tumour biological features of BRCA1-induced breast and ovarian cancerQ73347724
Risk models for familial ovarian and breast cancerQ73371929
Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage ConsortiumQ73375647
Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in PolandQ73400704
Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: implications for genetic testingQ73704841
Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer riskQ73806219
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based studyQ74157664
Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancersQ74405501
Frequency of breast cancer attributable to BRCA1 in a population-based series of American womenQ74449603
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriersQ74459364
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancerQ77845970
Variation in BRCA1 cancer risks by mutation positionQ77857319
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriersQ78198665
Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancerQ95721725
Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22Q57903143
Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast CancerQ59238528
A human BRCA1 gene knockoutQ60074873
Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast CancerQ61647812
Survival and tumor characteristics of German hereditary breast cancer patientsQ61970395
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2Q28212276
BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family historyQ28267644
Linkage of early-onset familial breast cancer to chromosome 17q21Q28268902
A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriersQ28387138
Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutationQ28586360
Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genesQ28768485
Biallelic inactivation of BRCA2 in Fanconi anemiaQ29616130
Identification of the breast cancer susceptibility gene BRCA2Q29616290
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage ConsortiumQ29619206
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the diseaseQ30665466
A systematic review of genetic polymorphisms and breast cancer risk.Q33766628
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage ConsortiumQ33894527
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotypeQ33904762
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibilityQ33904964
CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studiesQ33910280
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutationsQ33946674
Variation in cancer risks, by mutation position, in BRCA2 mutation carriersQ34044197
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genesQ34115258
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancerQ34145544
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersQ34162534
BRCA1 and BRCA2 and the genetics of breast and ovarian cancerQ34189009
Breast cancer, Cowden disease and PTEN-MATCHS syndromeQ34344820
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 geneQ34354479
ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancerQ34384444
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypesQ34385903
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancerQ34385912
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeatQ34389571
Cancer risks in BRCA2 mutation carriersQ34504452
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study GroupQ34512590
Cancer Incidence in BRCA1 mutation carriersQ34527264
Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalitiesQ34732377
Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, ColoradoQ35184354
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locusQ35209967
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.Q35238410
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi womenQ35238946
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.Q35643852
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidenceQ35644167
Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotypeQ35881865
BRCA1 mutations in southern EnglandQ36292995
Germline BRCA2 mutations in men with breast cancerQ36431527
Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French womenQ36438908
P53 germline mutations in childhood cancers and cancer risk for carrier individualsQ36621004
CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriersQ36623059
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in IsraelQ36642159
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancerQ37218535
Heterozygous ATM mutations do not contribute to early onset of breast cancerQ38348222
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from FinlandQ38492869
The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to AshkenazimQ38892074
Cancer risks in A-T heterozygotesQ40580171
Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populationsQ41194578
The complete BRCA2 gene and mutations in chromosome 13q-linked kindredsQ41226231
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancerQ42450903
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer familiesQ42691997
BRCA-associated breast cancer in young womenQ43459769
The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.Q43754304
BRCA2 germline mutations in male breast cancer patients in the Polish populationQ43840341
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.Q43974233
Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutationsQ44023983
The APCI1307K allele and breast cancer riskQ44930023
Polymorphisms associated with circulating sex hormone levels in postmenopausal womenQ44938215
A common variant in BRCA2 is associated with both breast cancer risk and prenatal viabilityQ45181384
Contributions of ATM mutations to familial breast and ovarian cancer.Q46062845
BRCA2 mutation in Icelandic prostate cancer patientsQ47618092
Cancer mortality in relatives of women with ovarian cancer: the OPCS Study. Office of Population Censuses and SurveysQ47648595
Cancer mortality in relatives of women with breast cancer: the OPCS Study. Office of Population Censuses and SurveysQ47648609
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutationsQ47696751
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.Q49231162
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?Q51051999
High constant incidence in twins and other relatives of women with breast cancer.Q53403578
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.Q53464409
p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predispositionQ55670947
Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2MutationQ57250729
Prediction of pathogenic mutations in patients with early-onset breast cancer by family historyQ57266776
Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationQ57266937
Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosomeQ57266956
Genome-wide scanning for linkage in Finnish breast cancer familiesQ57274804
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patientsQ57419184
Polyglutamine repeat length in theAIB1 gene modifies breast cancer susceptibility inBRCA1 carriersQ57499707
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study CollaboratorsQ57694684
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectbreast cancerQ128581
epidemiologyQ133805
P304page(s)221-236
P577publication date2004-07-01
P1433published inJournal of Mammary Gland Biology and NeoplasiaQ15724460
P1476titleThe genetic epidemiology of breast cancer genes
P478volume9

Reverse relations

cites work (P2860)
Q57138904Q57138904
Q42181679A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer
Q37272982A genome wide linkage search for breast cancer susceptibility genes
Q37024369A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protoc
Q36614153ATM haplotypes and breast cancer risk in Jewish high-risk women
Q37310896Acetylation Enhances the Promoting Role of AIB1 in Breast Cancer Cell Proliferation
Q38777072Alcohol consumption and breast cancer risk by family history of breast cancer and folate intake in younger women
Q33667724An investigation of breast cancer risk factors in Cyprus: a case control study
Q93271377Association of DEAR1 Tagging Single Nucleotide Polymorphisms With Breast Cancer in a Sample of Colombian Population: A Case Control Study
Q64948494BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance.
Q64284450BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers
Q49544412Biomarker Studies in Early Detection and Prognosis of Breast Cancer.
Q51820568Bovine tuberculosis: the genetic basis of host susceptibility.
Q37945448Breast cancer genome-wide association studies: there is strength in numbers
Q35490056Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations
Q37397658CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer
Q50645287Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome.
Q35889575Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Q34493797Common low-penetrance risk variants associated with breast cancer in Polish women
Q30478981Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study
Q36927199Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral
Q33985107Do alterations in mitochondrial DNA play a role in breast carcinogenesis?
Q54642509Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?
Q42640946Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study
Q30360376Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms
Q34865460Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study
Q37004792Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
Q35477949Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population
Q34938728Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families
Q34426529Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles
Q36243757Familial non-BRCA1/BRCA2-associated breast cancer
Q54587377Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.
Q38041587Genetic determinants of breast cancer risk: a review of current literature and issues pertaining to clinical application
Q37156413Genetic susceptibility loci for breast cancer by estrogen receptor status
Q41130542Genetic susceptibility to breast cancer
Q34295620Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women
Q51691340Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus.
Q54249734Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas.
Q45972889Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families.
Q44358800Germline mutations in RAD51C in Jewish high cancer risk families
Q34425230Hereditary breast cancer: clinical, pathological and molecular characteristics
Q86824997Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation
Q35105646High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients.
Q36041250Hypothesis: Activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer
Q34743854Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm
Q37670809Implications of single nucleotide polymorphisms in CD44 exon 2 for risk of breast cancer
Q37378034Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model
Q36925229Inherited and acquired alterations in development of breast cancer.
Q36067806Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
Q33483075Low-risk susceptibility alleles in 40 human breast cancer cell lines
Q38153187Male breast cancer: genetics, epigenetics, and ethical aspects.
Q38844679Management of women with a hereditary predisposition for breast cancer
Q36602581Models of genetic susceptibility to breast cancer
Q90413979Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management
Q36623385Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein
Q33258847Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families
Q33348765Novel de novo BRCA2 mutation in a patient with a family history of breast cancer
Q35939849Obesity is a significant risk factor for breast cancer in Arab women
Q38843992Olaparib for the treatment of breast cancer.
Q37925056Oral cancer in young non-habituè females: a report of four cases and review of the literature
Q55110010Pathology of hereditary breast cancer.
Q34023724Pattern response of dendritic cells in the tumor microenvironment and breast cancer
Q50997123Platform comparisons for identification of breast cancers with a BRCA-like copy number profile.
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q33916899Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study
Q51808027Psychosocial and ethical issues relating to genetic testing for BRCA1 and BRCA2 breast cancer susceptibility genes.
Q58739875Rapid detection of copy number variations and point mutations in genes using a single workflow by ion semiconductor sequencing pipeline
Q37373918Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer
Q28743906Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study
Q35962026Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario
Q35181094Review: mitochondrial defects in breast cancer
Q36430753Risk prediction models for familial breast cancer
Q54093040SYK expression level distinguishes control from BRCA1-mutated lymphocytes.
Q50548721Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.
Q33395135Selecting a BRCA risk assessment model for use in a familial cancer clinic
Q41387543Six low-penetrance SNPs for the estimation of breast cancer heritability: A family-based study in Caucasian Italian patients
Q36611450TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer
Q35180956The 'Pokemon' (ZBTB7) Gene: No Evidence of Association with Sporadic Breast Cancer.
Q37665532The LSP1 rs3817198 T > C polymorphism contributes to increased breast cancer risk: a meta-analysis of twelve studies
Q82987365The Mcs7 quantitative trait locus is associated with an increased susceptibility to mammary cancer in congenic rats and an allele-specific imbalance
Q57272203The emerging landscape of breast cancer susceptibility
Q28074414The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance
Q35747645Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden
Q50281677Unique CD44 intronic SNP is associated with tumor grade in breast cancer: a case control study and in silico analysis.
Q34069483Unique SNP in CD44 intron 1 and its role in breast cancer development.
Q30423128Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
Q33636005Variation in genes required for normal mitosis and risk of breast cancer

Search more.